Moderna shares slide after sales guidance slashed
Published
Stock plunge of 22% comes as vaccine maker grapples with shrinking market for Covid jabs
Full ArticlePublished
Stock plunge of 22% comes as vaccine maker grapples with shrinking market for Covid jabs
Full Article